La Queue du Chat

Respiratory Motion, Inc.

is a U.S. medical device company specializing in respiratory monitoring. The company focuses on non-invasive minute ventilation monitoring for patients in hospitals and other care settings. Its flagship product, ExSpiron, is designed to measure breathing volume, tidal volume, and respiratory rate, providing early warnings of respiratory decline. The company develops and commercializes devices and systems aimed at monitoring respiratory function and other vital signs. Its mission is to enhance patient safety, support clinicians, and reduce healthcare costs. Based in Watertown/Waltham, Massachusetts, Respiratory Motion was acquired by Senzime in 2022. The ExSpiron product line includes the ExSpiron 1Xi, a continuous respiratory monitor that graphically displays lung volumes over time and reports key respiratory metrics. The technology is applicable across various patient populations and care environments.